Quantcast

Latest Endo Pharmaceuticals Stories

2014-02-03 08:27:32

MALVERN, Penn., Feb. 3, 2014 /PRNewswire/ -- -- Unique Generics Product Portfolio, Attractive Pipeline, Builds On Qualitest's Strength In Controlled Substances -- Transaction Expected To Be Immediately Accretive To Endo's Adjusted Diluted EPS Endo Health Solutions (Nasdaq: ENDP) today announced that its Qualitest subsidiary has completed the acquisition of privately held Boca Pharmacal, a specialty pharmaceutical company, for approximately $225 million in cash....

2014-01-29 16:28:52

MALVERN, Pa., Jan. 29, 2014 /PRNewswire/ -- Endo Health Solutions (Nasdaq: ENDP) today confirmed that the United States District Court for the District of Delaware ruled that United States Patent No. 5,464,864, Endo's patent covering frovatriptan, the active ingredient in FROVA(® )(frovatriptan succinate) tablets, is valid and infringed. The Court's decision prevents Mylan from marketing its generic version of FROVA(®) in the U.S. before Endo's patent expires November 8, 2015,...

2014-01-10 08:23:03

BEMA Buprenorphine Phase 3 opioid naive study database lock imminent; triggers $10M milestone payment from Endo Pharmaceuticals RALEIGH, N.C., Jan. 10, 2014 /PRNewswire/ -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced updates to the company's anticipated 2014 milestones for its product portfolio, including the imminent database lock for the Phase 3 clinical study of BEMA Buprenorphine for the treatment of moderate to severe chronic pain in opioid naive subjects, with...

2014-01-09 08:27:47

MALVERN, Pa., Jan. 9, 2014 /PRNewswire/ -- -- Altaris Capital Partners to acquire HealthTronics for a total consideration of up to $130 million including $85 Million in cash upfront -- HealthTronics is a national provider of urological products and services Endo Health Solutions (Nasdaq: ENDP) today announced it has entered into a definitive agreement to sell its HealthTronics business to Altaris Capital Partners, LLC for an upfront cash payment of $85 million,...

2014-01-08 08:26:20

Leading Specialty Healthcare Practice Deepens Agency's Men's Health and Pain Expertise NEW YORK, Jan. 8, 2013 /PRNewswire/ -- Ogilvy Public Relations (Ogilvy PR), an integrated global communications firm, today announced that Endo Health Solutions, Inc., a U.S.-based specialty healthcare company that strives to provide quality products and improve the lives of patients, has appointed Ogilvy Public Relations (Ogilvy PR) as an agency partner for its Endo Pharmaceuticals division....

2013-12-05 23:04:28

Reportbuyer.com just published a new market research report: Drug Delivery Partnering Terms and Agreements. London (PRWEB) December 05, 2013 The Drug Delivery Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the drug delivery partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides a detailed understanding and analysis of how and why companies enter drug delivery partnering deals....


Word of the Day
reremouse
  • A bat.
The word 'reremouse' comes from Middle English reremous, from Old English hrēremūs, hrērmūs ("bat"), equivalent to rear (“to move, shake, stir”) +‎ mouse.
Related